C12N 2740/13052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2740/13052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 101 US grants and 59 published applications in this corpus.
Search patents in C12N- Granted patents
- 101
- Published applications
- 59
- Assignees
- 76
- Inventors
- 217
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 8 | 0 |
| 1998 | 13 | 0 |
| 1999 | 13 | 0 |
| 2000 | 8 | 0 |
| 2001 | 7 | 1 |
| 2002 | 8 | 5 |
| 2003 | 4 | 3 |
| 2004 | 3 | 5 |
| 2005 | 1 | 2 |
| 2006 | 4 | 5 |
| 2007 | 1 | 2 |
| 2008 | 1 | 2 |
| 2009 | 1 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 3 |
| 2013 | 0 | 0 |
| 2014 | 3 | 2 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 2 | 2 |
| 2022 | 0 | 1 |
| 2023 | 3 | 6 |
| 2024 | 2 | 3 |
| 2025 | 3 | 4 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for therapeutic or vaccine delivery8 Jul 2025US 12,350,327 B2GenVivo, Inc.
- Retroviral vector27 May 2025US 12,312,592 B2Oxford Biomedica (UK) Limited
- Digital-to-analog conversion apparatus and method having signal calibration mechanism21 Jan 2025US 12,203,093 B2Realtek Semiconductor Corp.
- Compositions and methods for therapeutic or vaccine delivery28 May 2024US 11,992,524 B2GenVivo, Inc.
- Plasmid system23 Apr 2024US 11,965,173 B2Autolus Limited
- Pseudotyped viral particles for targeting tcr-expressing cells6 Aug 2026US 2026/0226500 A1Regeneron Pharmaceuticals, Inc.
- Transduction of gammadelta T cells with pseudotyped retroviral vectors28 May 2026US 2026/0146260 A1Miltenyi Biotec GmbH
- Retroviral and Lentiviral Vectors25 Dec 2025US 2025/0388929 A1Autolus Limited
- Compositions and methods for therapeutic or vaccine delivery13 Nov 2025US 2025/0345409 A1GenVivo, Inc.
- Compositions and methods for efficient in vivo delivery1 May 2025US 2025/0136950 A1Nvelop Therapeutics, Inc.
Most cited
By later US patents
- DNA constructs for retrovirus packaging cell lines249US 4,861,719 AFred Hutchinson Cancer Research Center · 1989
- Recombination resistant retroviral helper cell and products produced thereby142US 5,124,263 AWisconsin Alumni Research Foundation · 1992
- Internal ribosome entry site, vector containing it and therapeutic use107US 5,925,565 AInstitut National de la Sante et de la Recherche Medicale · 1999
- Retroviral packaging cell lines and process of using same102US 5,278,056 AThe Trustees of Columbia University in the City of New York · 1994
- Retrovirus and viral vectors88US 6,635,472 B1Rubicon Laboratory, Inc. · 2003